C. Ram‐Wolff

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

CCR4 as a Therapeutic Target for Cancer Immunotherapy

How I treat mycosis fungoides and Sézary syndrome

Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?

Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases

CD158k Is a Reliable Marker for Diagnosis of Sézary Syndrome and Reveals an Unprecedented Heterogeneity of Circulating Malignant Cells

Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas